P38γ mitogen-activated protein kinase suppresses chondrocyte production of MMP-13 in response to catabolic stimulation

Osteoarthritis and Cartilage

Volumn 18, Issue 9, 2010, Pages 1203-1210

  Long, D L ^a   Loeser, R F ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Articular cartilage; Cell signaling; Chondrocyte; Cytokines; Integrins; Matrix metalloproteinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGENASE 3; DORAMAPIMOD; FIBRONECTIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE 13; MITOGEN ACTIVATED PROTEIN KINASE 14; OSTEOGENIC PROTEIN 1; SOMATOMEDIN C; PEPTIDE FRAGMENT; SIGNAL PEPTIDE;

ARTICLE; CARTILAGE CELL; CATABOLISM; CELL STIMULATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; ARTICULAR CARTILAGE; DOWN REGULATION; DRUG EFFECT; INFLAMMATION; METABOLISM; OSTEOARTHRITIS;

CARTILAGE, ARTICULAR; CHONDROCYTES; DOWN-REGULATION; FIBRONECTINS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 13; MITOGEN-ACTIVATED PROTEIN KINASE 12; OSTEOARTHRITIS; PEPTIDE FRAGMENTS;

EID: 77956010447     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.05.016     Document Type: Article

References (36)

1. Kumar S., Boehm J., Lee J.C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003, 2:717-726.
2. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
3. Jiang Y., Chen C., Li Z., Guo W., Gegner J.A., Lin S., et al. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem 1996, 271:17920-17926.
4. Li Z., Jiang Y., Ulevitch R.J., Han J. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 1996, 228:334-340.
5. Jiang Y., Gram H., Zhao M., New L., Gu J., Feng L., et al. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J Biol Chem 1997, 272:30122-30128.
6. Homandberg G.A. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Front Biosci 1999, 4:D713-730.
7. Mitchell P.G., Magna H.A., Reeves L.M., Lopresti-Morrow L.L., Yocum S.A., Rosner P.J., et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996, 97:761-768.
8. Smeets T.J., Kraan M.C., Galjaard S., Youssef P.P., Smith M.D., Tak P.P. Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA. Ann Rheum Dis 2001, 60:561-565.
9. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 2000, 43:801-811.
10. Forsyth C.B., Pulai J., Loeser R.F. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 2002, 46:2368-2376.
11. Loeser R.F., Forsyth C.B., Samarel A.M., Im H.J. Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem 2003, 278:24577-24585.
12. Ding L., Guo D., Homandberg G.A. The cartilage chondrolytic mechanism of fibronectin fragments involves MAP kinases: comparison of three fragments and native fibronectin. Osteoarthritis Cartilage 2008, 16:1253-1262.
13. Korb A., Tohidast-Akrad M., Cetin E., Axmann R., Smolen J., Schett G. Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis. Arthritis Rheum 2006, 54:2745-2756.
14. Masuko-Hongo K., Berenbaum F., Humbert L., Salvat C., Goldring M.B., Thirion S. Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. Arthritis Rheum 2004, 50:2829-2838.
15. Ruettger A., Schueler S., Mollenhauer J.A., Wiederanders B. Cathepsins B, K, and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes. J Biol Chem 2008, 283:1043-1051.
16. Kuma Y., Sabio G., Bain J., Shpiro N., Marquez R., Cuenda A. BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J Biol Chem 2005, 280:19472-19479.
17. Leahy D.J., Aukhil I., Erickson H.P. 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 1996, 84:155-164.
18. Muehleman C., Bareither D., Huch K., Cole A.A., Kuettner K.E. Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthritis Cartilage 1997, 5:23-37.
19. Avitzour M., Diskin R., Raboy B., Askari N., Engelberg D., Livnah O. Intrinsically active variants of all human p38 isoforms. FEBS J 2007, 274:963-975.
20. Pulai J.I., Chen H., Im H.J., Kumar S., Hanning C., Hegde P.S., et al. NF-κB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 2005, 174:5781-5788.
21. Pratt P.F., Bokemeyer D., Foschi M., Sorokin A., Dunn M.J. Alterations in subcellular localization of p38 MAPK potentiates endothelin-stimulated COX-2 expression in glomerular mesangial cells. J Biol Chem 2003, 278:51928-51936.
22. Court N.W., dos Remedios C.G., Cordell J., Bogoyevitch M.A. Cardiac expression and subcellular localization of the p38 mitogen-activated protein kinase member, stress-activated protein kinase-3 (SAPK3). J Mol Cell Cardiol 2002, 34:413-426.
23. Qi X., Pohl N.M., Loesch M., Hou S., Li R., Qin J.Z., et al. p38alpha antagonizes p38gamma activity through c-Jun-dependent ubiquitin-proteasome pathways in regulating Ras transformation and stress response. J Biol Chem 2007, 282:31398-31408.
24. Lee J.C., Kassis S., Kumar S., Badger A., Adams J.L. p38 mitogen-activated protein kinase inhibitors-mechanisms and therapeutic potentials. Pharmacol Ther 1999, 82:389-397.
25. Cuenda A., Cohen P., Buee-Scherrer V., Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 1997, 16:295-305.
26. Fan Z., Bau B., Yang H., Soeder S., Aigner T. Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin-1beta. Arthritis Rheum 2005, 52:136-143.
27. Im H.J., Pacione C., Chubinskaya S., Van Wijnen A.J., Sun Y., Loeser R.F. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem 2003, 278:25386-25394.
28. Junttila M.R., Ala-Aho R., Jokilehto T., Peltonen J., Kallajoki M., Grenman R., et al. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells. Oncogene 2007, 26:5267-5279.
29. Pramanik R., Qi X., Borowicz S., Choubey D., Schultz R.M., Han J., et al. p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J Biol Chem 2003, 278:4831-4839.
30. Askari N., Diskin R., Avitzour M., Capone R., Livnah O., Engelberg D. Hyperactive variants of p38alpha induce, whereas hyperactive variants of p38gamma suppress, activating protein 1-mediated transcription. J Biol Chem 2007, 282:91-99.
31. Hegen M., Gaestel M., Nickerson-Nutter C.L., Lin L.L., Telliez J.B. MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol 2006, 177:1913-1917.
32. Jones S.W., Brockbank S.M., Clements K.M., Le Good N., Campbell D., Read S.J., et al. Mitogen-activated protein kinase-activated protein kinase 2 (MK2) modulates key biological pathways associated with OA disease pathology. Osteoarthritis Cartilage 2009, 17:124-131.
33. Kang Y.J., Seit-Nebi A., Davis R.J., Han J. Multiple activation mechanisms of p38alpha mitogen-activated protein kinase. J Biol Chem 2006, 281:26225-26234.
34. Enslen H., Brancho D.M., Davis R.J. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J 2000, 19:1301-1311.
35. Alonso G., Ambrosino C., Jones M., Nebreda A.R. Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J Biol Chem 2000, 275:40641-40648.
36. Namdari S., Wei L., Moore D., Chen Q. Reduced limb length and worsened osteoarthritis in adult mice after genetic inhibition of p38 MAP kinase activity in cartilage. Arthritis Rheum 2008, 58:3520-3529.